The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED)
Clinical trial NCT00251641 · COMPLETED
Trial details
- NCT number
- NCT00251641
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2008-06-01
- Enrollment
- 868
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.